Compare NPK & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPK | CERT |
|---|---|---|
| Founded | 1905 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1994 | 2020 |
| Metric | NPK | CERT |
|---|---|---|
| Price | $146.07 | $8.61 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $11.67 |
| AVG Volume (30 Days) | 75.9K | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $503,524,000.00 | $418,838,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | $152.47 | ★ N/A |
| Revenue Growth | ★ 29.70 | 8.75 |
| 52 Week Low | $91.28 | $4.45 |
| 52 Week High | $158.17 | $13.88 |
| Indicator | NPK | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | N/A |
| Support Level | $121.33 | N/A |
| Resistance Level | $157.42 | N/A |
| Average True Range (ATR) | 4.34 | 0.00 |
| MACD | -0.72 | 0.00 |
| Stochastic Oscillator | 52.94 | 0.00 |
National Presto Industries Inc has an electric product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments, namely Defense, Housewares/Small Appliance, and Safety. The defense segment, which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases, performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While the Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances, the safety segment provides safety technology empowering organizations and individuals to protect what is more important.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.